A mutant bispecific antibody that includes (a) a human hinge constant regionfrom IgG having one or more amino acid mutations in the CH2 domain, (b) twoSCFVS; and (c) two FVS has been constructed. This type of antibody displaysenhanced clearance, which has been found to be particularly useful in thecontext of pre-targeting methods.